Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. The purpose of the 24-week trial is to investigate the efficacy of henagliflozin to induce body weight loss and the purpose of the extension is to evaluate the hypoglycemic effect of henagliflozin in obese subjects without diabetes.
Trial has the following two periods: 1) A 12-week randomized, double-blind, placebo-controlled, multi-center trial for evaluating the efficacy of henagliflozin to induce body weight loss; 2) A 12-week multicenter randomized controlled open-label trial for evaluating the hypoglycemic effect of henagliflozin followed by a 24-week extension period.
Phase:
PHASE4
Details
Lead Sponsor:
The First People's Hospital of Changzhou
Collaborators:
Affiliated Hospital of Jiangsu University Northern Jiangsu People's Hospital Second Affiliated Hospital of Soochow University The Affiliated Hospital of Xuzhou Medical University The First Affiliated Hospital of Soochow University The First People's Hospital of Lianyungang The fourth affiliated hospital of nantong university The Second Hospital of Nanjing Medical University Wuxi People's Hospital